Literature DB >> 6507135

Effect of prostaglandin inhibition on the renal vascular response to ionic and non-ionic contrast media in the dog.

G Lund, S Einzig, J Rysavy, E Salomonowitz, W Castaneda-Zuniga, K Amplatz.   

Abstract

In an attempt to study the role of prostaglandins in the renal vascular response to contrast media in mongrel dogs, renal arterial injections of 6 ml of either the non-ionic contrast medium Iopamidol or the ionic medium diatrizoate meglumine/Na+ were performed, before and after intravenous injection of a buffered solution of acetylsalicylic acid (10 mg/kg) (ASA). Renal blood flow was recorded using non-occluding electromagnetic flow probes. The resting renal blood flow was significantly reduced after ASA. The usual biphasic response to contrast injection was observed both before and after ASA, and using either contrast medium. Analysis of the results failed to show any difference in degree of vasodilation or vasoconstriction after ASA. We conclude that prostaglandins may affect the resting level of renal blood flow but are not mediators of the instantaneous changes in response to contrast injection.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6507135     DOI: 10.1177/028418518402500511

Source DB:  PubMed          Journal:  Acta Radiol Diagn (Stockh)        ISSN: 0567-8056


  3 in total

1.  Intravenous urography with iopamidol in children with reflux and obstructive nephropathy: effects on glomerular and tubular functions and the renin-angiotensin-aldosterone system.

Authors:  M Bosio; F Bissoli; G Vignati; M G Fiori
Journal:  Pediatr Nephrol       Date:  1990-05       Impact factor: 3.714

2.  Adenosine A1 receptors in contrast media-induced renal dysfunction in the normal rat.

Authors:  Per Liss; Per-Ola Carlsson; Fredrik Palm; Peter Hansell
Journal:  Eur Radiol       Date:  2004-01-09       Impact factor: 5.315

Review 3.  Isolevuglandins as mediators of disease and the development of dicarbonyl scavengers as pharmaceutical interventions.

Authors:  Sean S Davies; Linda S May-Zhang; Olivier Boutaud; Venkataraman Amarnath; Annet Kirabo; David G Harrison
Journal:  Pharmacol Ther       Date:  2019-10-16       Impact factor: 12.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.